We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATSG
76
DELISTED
Air Transport Services Group
ATSG
$7.68M 0.27%
245,222
-64,442
-21% -$1.88M
FIVE icon
77
Five Below
FIVE
$13.1B
$7.05M 0.25%
40,278
-13,686
-25% -$2.03M
ASND icon
78
Ascendis Pharma A/S
ASND
$16.7B
$7M 0.25%
41,983
+19,696
+88% +$3.26M
INMD icon
79
InMode
INMD
$871M
$6.93M 0.24%
291,770
+34,492
+13% +$729K
LOPE icon
80
Grand Canyon Education
LOPE
$3.84B
$6.68M 0.24%
71,723
-26,240
-27% -$2.24M
BMRN icon
81
BioMarin Pharmaceuticals
BMRN
$13.3B
$6.64M 0.23%
75,748
-5,125
-6% -$406K
ACLS icon
82
Axcelis
ACLS
$4.11B
$6.58M 0.23%
226,056
-49,379
-18% -$1.28M
PRGS icon
83
Progress Software
PRGS
$1.78B
$6.52M 0.23%
144,307
-43,945
-23% -$1.78M
CSII
84
DELISTED
Cardiovascular Systems, Inc.
CSII
$6.49M 0.23%
148,381
-25,129
-14% -$946K
FN icon
85
Fabrinet
FN
$19.1B
$6.22M 0.22%
80,149
-7,606
-9% -$517K
PBYI icon
86
Puma Biotechnology
PBYI
$452M
$6.21M 0.22%
604,937
+23,942
+4% +$242K
CDNA icon
87
CareDx
CDNA
$2.45B
$6.04M 0.21%
83,377
-129,849
-61% -$7.52M
MODN
88
DELISTED
MODEL N, INC.
MODN
$6.01M 0.21%
168,336
-39,930
-19% -$1.38M
OR icon
89
OR Royalties Inc
OR
$6.34B
$5.75M 0.2%
453,639
+207,351
+84% +$2.42M
LSCC icon
90
Lattice Semiconductor
LSCC
$18.5B
$5.67M 0.2%
123,751
-78,543
-39% -$3.04M
ROCK icon
91
Gibraltar Industries
ROCK
$1.45B
$5.65M 0.2%
78,486
-10,524
-12% -$703K
VIAV icon
92
Viavi Solutions
VIAV
$9.27B
$5.6M 0.2%
374,220
+38,671
+12% +$514K
VICR icon
93
Vicor
VICR
$9.73B
$5.59M 0.2%
60,653
-15,285
-20% -$1.28M
TTD icon
94
Trade Desk
TTD
$6.15B
$5.48M 0.19%
68,400
-161,470
-70% -$12.2M
PZZA icon
95
Papa John's
PZZA
$777M
$5.39M 0.19%
63,491
-18,353
-22% -$1.5M
ENSG icon
96
The Ensign Group
ENSG
$10.7B
$5.28M 0.19%
72,411
-14,621
-17% -$969K
IRMD icon
97
iRadimed
IRMD
$1.15B
$5.22M 0.18%
228,794
+7,287
+3% +$168K
MATX icon
98
Matsons
MATX
$6.24B
$5.18M 0.18%
90,900
-43,552
-32% -$2.38M
OMCL icon
99
Omnicell
OMCL
$1.69B
$5.16M 0.18%
42,955
-44,750
-51% -$4.39M
EPAM icon
100
EPAM Systems
EPAM
$5.05B
$5.14M 0.18%
14,350
-9,134
-39% -$3.05M
2 3
4
5 6

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.